| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 7 |
| NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: A4I235
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 8 |
| GO:0003723 | RNA binding | 4 | 8 |
| GO:0005488 | binding | 1 | 8 |
| GO:0097159 | organic cyclic compound binding | 2 | 8 |
| GO:1901363 | heterocyclic compound binding | 2 | 8 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 310 | 314 | PF00656 | 0.675 |
| CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.674 |
| CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.674 |
| CLV_PCSK_SKI1_1 | 133 | 137 | PF00082 | 0.709 |
| CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.317 |
| DEG_COP1_1 | 13 | 23 | PF00400 | 0.498 |
| DEG_SCF_FBW7_2 | 284 | 291 | PF00400 | 0.768 |
| DOC_CKS1_1 | 285 | 290 | PF01111 | 0.696 |
| DOC_MAPK_HePTP_8 | 237 | 249 | PF00069 | 0.521 |
| DOC_MAPK_MEF2A_6 | 240 | 249 | PF00069 | 0.565 |
| DOC_USP7_MATH_1 | 248 | 252 | PF00917 | 0.472 |
| DOC_USP7_MATH_1 | 267 | 271 | PF00917 | 0.608 |
| DOC_USP7_MATH_1 | 294 | 298 | PF00917 | 0.725 |
| DOC_USP7_MATH_1 | 309 | 313 | PF00917 | 0.597 |
| DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.423 |
| DOC_USP7_MATH_1 | 58 | 62 | PF00917 | 0.485 |
| DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.517 |
| DOC_WW_Pin1_4 | 189 | 194 | PF00397 | 0.709 |
| DOC_WW_Pin1_4 | 265 | 270 | PF00397 | 0.581 |
| DOC_WW_Pin1_4 | 284 | 289 | PF00397 | 0.695 |
| DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.586 |
| LIG_14-3-3_CanoR_1 | 30 | 38 | PF00244 | 0.448 |
| LIG_BRCT_BRCA1_1 | 131 | 135 | PF00533 | 0.712 |
| LIG_BRCT_BRCA1_1 | 68 | 72 | PF00533 | 0.509 |
| LIG_FHA_1 | 100 | 106 | PF00498 | 0.545 |
| LIG_FHA_1 | 19 | 25 | PF00498 | 0.508 |
| LIG_FHA_2 | 299 | 305 | PF00498 | 0.702 |
| LIG_FHA_2 | 4 | 10 | PF00498 | 0.704 |
| LIG_GSK3_LRP6_1 | 265 | 271 | PF00069 | 0.583 |
| LIG_LIR_Apic_2 | 79 | 83 | PF02991 | 0.517 |
| LIG_LIR_Gen_1 | 203 | 209 | PF02991 | 0.556 |
| LIG_LIR_Nem_3 | 246 | 252 | PF02991 | 0.565 |
| LIG_LIR_Nem_3 | 4 | 8 | PF02991 | 0.590 |
| LIG_LIR_Nem_3 | 51 | 56 | PF02991 | 0.520 |
| LIG_LIR_Nem_3 | 60 | 65 | PF02991 | 0.513 |
| LIG_PDZ_Class_3 | 323 | 328 | PF00595 | 0.755 |
| LIG_SH2_CRK | 80 | 84 | PF00017 | 0.517 |
| LIG_SH2_STAP1 | 205 | 209 | PF00017 | 0.591 |
| LIG_SH2_STAT3 | 32 | 35 | PF00017 | 0.452 |
| LIG_SH2_STAT5 | 252 | 255 | PF00017 | 0.564 |
| LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.417 |
| LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.555 |
| LIG_SH3_1 | 261 | 267 | PF00018 | 0.720 |
| LIG_SH3_3 | 261 | 267 | PF00018 | 0.762 |
| LIG_SH3_3 | 52 | 58 | PF00018 | 0.555 |
| LIG_SUMO_SIM_par_1 | 112 | 118 | PF11976 | 0.630 |
| LIG_WRC_WIRS_1 | 2 | 7 | PF05994 | 0.640 |
| MOD_CK1_1 | 117 | 123 | PF00069 | 0.652 |
| MOD_CK1_1 | 171 | 177 | PF00069 | 0.671 |
| MOD_CK1_1 | 268 | 274 | PF00069 | 0.725 |
| MOD_CK2_1 | 298 | 304 | PF00069 | 0.712 |
| MOD_CK2_1 | 48 | 54 | PF00069 | 0.439 |
| MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.688 |
| MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.774 |
| MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.720 |
| MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.555 |
| MOD_GlcNHglycan | 67 | 71 | PF01048 | 0.314 |
| MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.321 |
| MOD_GSK3_1 | 114 | 121 | PF00069 | 0.633 |
| MOD_GSK3_1 | 157 | 164 | PF00069 | 0.685 |
| MOD_GSK3_1 | 265 | 272 | PF00069 | 0.683 |
| MOD_GSK3_1 | 294 | 301 | PF00069 | 0.704 |
| MOD_GSK3_1 | 44 | 51 | PF00069 | 0.563 |
| MOD_GSK3_1 | 72 | 79 | PF00069 | 0.517 |
| MOD_N-GLC_1 | 171 | 176 | PF02516 | 0.719 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.650 |
| MOD_NEK2_1 | 115 | 120 | PF00069 | 0.621 |
| MOD_NEK2_1 | 136 | 141 | PF00069 | 0.704 |
| MOD_NEK2_1 | 276 | 281 | PF00069 | 0.672 |
| MOD_NEK2_1 | 72 | 77 | PF00069 | 0.517 |
| MOD_PIKK_1 | 136 | 142 | PF00454 | 0.761 |
| MOD_PIKK_1 | 164 | 170 | PF00454 | 0.581 |
| MOD_PIKK_1 | 31 | 37 | PF00454 | 0.443 |
| MOD_PKA_2 | 136 | 142 | PF00069 | 0.675 |
| MOD_PKA_2 | 157 | 163 | PF00069 | 0.710 |
| MOD_Plk_1 | 84 | 90 | PF00069 | 0.542 |
| MOD_Plk_4 | 248 | 254 | PF00069 | 0.613 |
| MOD_ProDKin_1 | 189 | 195 | PF00069 | 0.707 |
| MOD_ProDKin_1 | 265 | 271 | PF00069 | 0.583 |
| MOD_ProDKin_1 | 284 | 290 | PF00069 | 0.696 |
| MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.590 |
| MOD_SUMO_for_1 | 49 | 52 | PF00179 | 0.555 |
| MOD_SUMO_rev_2 | 206 | 214 | PF00179 | 0.656 |
| TRG_ENDOCYTIC_2 | 205 | 208 | PF00928 | 0.548 |
| TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.527 |
| TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.505 |
| TRG_ER_diArg_1 | 220 | 222 | PF00400 | 0.659 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P6I9 | Leptomonas seymouri | 60% | 98% |
| A0A3Q8ICS1 | Leishmania donovani | 100% | 100% |
| A0A422NSU1 | Trypanosoma rangeli | 42% | 100% |
| A4HEW2 | Leishmania braziliensis | 82% | 100% |
| E9AY85 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
| Q4Q988 | Leishmania major | 92% | 100% |